Sexual harassment complaints: 2 FIRs registered against Wrestling Federation of India chief, 1 of them under Pocso
Coronavirus situation under control in Delhi, not terrible, says Kejriwal
Maruti reports 54% YoY decline in sales in June; sells less than 40% of pre-coronavirus level
Government Bans 59 Chinese Apps Including Tik-Tok, Shareit, UC Browser, and WeChat
PM Modi to address the nation at 4 pm: What to expect
Maharashtra Extends Lockdown Till July 31 Day After Urging Caution
Coronavirus Vaccine Update
Swarms Of Desert Locusts Reach Delhi Outskirts After Gurugram
Delhi fighting difficult battle against COVID-19, will emerge victorious: Kejriwal
2-Week Lockdown In Guwahati From Monday; Minister Says "Shop By Sunday"
YouTube likely to come up with TikTok-like short video platform
Rs 2,000 crore from PM CARES Fund to be spent on 50,0000 ventilators for COVID-19 patients
Baba Ramdev's Patanjali launches India's 'first Ayurvedic' medicine for coronavirus, Coronil
Coronavirus: Glenmark conducts Fabiflu trial on 1,000 patients; to compete with Gilead's Remdesivir
Jio's golden touch makes Reliance Industries share rise 108% in 3 months
Coronavirus vaccine: When will it be ready? Moderna, AstraZeneca offer answers
Chennai lockdown starts today: Check what is allowed, not allowed
Coronavirus vaccine: Singapore scientists discover 5 antibodies that can combat COVID-19
India-China tension: Indian Army releases list of 20 martyrs; wreath ceremony begins in Leh
Tamil Nadu announces 'maximised restricted lockdown' from June 19 in Chennai, 3 other districts

Latest Posts

Coronavirus vaccine: When will it be ready? Moderna, AstraZeneca offer answers

latest news update

The search for a coronavirus vaccine has reached its zenith. While some researchers have progressed to advanced stages of trials, some have already put out a time frame for the release of the corona vaccine. World Health Organisation expects nearly 2 billion doses of COVID-19 vaccine to be ready by the end of next year. Moderna, one of the leading contenders for the coronavirus vaccine said that there's a high probability of their candidate reaching the distribution stage in 2021. Germany's CureVac AG is also aiming for mid-2021 release of its coronavirus vaccine candidate.

Here's the latest updates on coronavirus vaccine research and development:

WHO Chief Scientist Dr Soumya Swaminathan said that she expects nearly 2 billion doses of a COVID vaccine by the end of next year. "At the moment we do not have a proven vaccine but if we are lucky, there will be one of two successful candidates before the end of this year and 2 billion doses by the end of next year," she said while addressing the media from Geneva. There are currently over 100 vaccines under trial.

Moderna is preparing to launch Phase 3 of the trials in July. CEO Stephane Bancel said that there was a high probability that the company's product could reach the distribution stage in 2021. Bancel said that they are anticipating the efficacy data to be out by Thanksgiving. Moderna is aiming to recruit 30,000 people for its Phase 3 of trials. "We are very, very interested in knowing as much as we can about this vaccine and to ensure it is safe," he said. Bancel said that the company has worked upon several vaccines over the years that helped in speeding up their process. "This was actually the 10th vaccine that we put in clinical trial. We've learned a lot over the years: how to optimise the manufacturing process, how to optimise your chemistry, to get the best vaccine we could," said the CEO.

AstraZeneca that is producing the corona vaccine candidate developed by Oxford University said that they could deliver the candidate by October if everything goes well. AstraZeneca CEO Pascal Soriot said that their potential COVID-19 vaccine candidate is likely to provide protection for a year. "We think that it will protect for about a year," Soriot said. The company has already started human trials.

Germany's CureVac AG has said that if approved, their coronavirus vaccine candidate could be on the market by mid-2021. Klaus Cichutek, President of German vaccine regulator PEI said that the company might be able to apply for approval by early 2021. The company has received approval from the government to conduct trials on 168 health people.

Imperial College London that is conducting human clinical trials of the coronavirus vaccine hopes to have a viable candidate by April 2021. The human trials of the corona vaccine candidate will reveal its efficacy and safety. "From a scientific perspective, new technologies mean we have been able to get moving on a potential vaccine with unprecedented speed. We've been able to produce a vaccine from scratch and take it to human trials in just a few months - from code to candidate - which has never been done before with this type of vaccine," said Professor Robin Shattock from the Department of Infectious Disease at Imperial College.


Alert Message

Please Wait...

Share the Opinion Poll with your Friends At


Share the Survey with your
Friends At